Arkolith/Insider Trading/BCRX/Form 4

Stonehouse Jon P

DirectorBIOCRYST PHARMACEUTICALS INC (BCRX) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Disposed to issuer(D)306K$8.64$2.6M1.3M
Mar 2, 2026Option exercise(M)306K$3.22$985K1.6M
Feb 27, 2026Grant(A)421$8.75$4K1.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)306K—$00

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000882796-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML